Raras
Buscar doenças, sintomas, genes...
Retinopatia da prematuridade
ORPHA:90050CID-10 · H35.1CID-11 · 9B71.3DOENÇA RARA

Uma doença que afeta a retina dos dois olhos. Ela é caracterizada pelo crescimento de vasos sanguíneos anormais, formação de cicatrizes, descolamento da retina e, por fim, pode levar à cegueira. Pode ser leve ou grave. Acontece em bebês que nascem prematuros. As causas incluem o excesso ou a falta de oxigênio.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Uma doença que afeta a retina dos dois olhos. Ela é caracterizada pelo crescimento de vasos sanguíneos anormais, formação de cicatrizes, descolamento da retina e, por fim, pode levar à cegueira. Pode ser leve ou grave. Acontece em bebês que nascem prematuros. As causas incluem o excesso ou a falta de oxigênio.

Pesquisas ativas
25 ensaios
183 total registrados no ClinicalTrials.gov
Publicações científicas
9.525 artigos
Último publicado: 2026 Apr 16

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-5 / 10 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Europe
Início
Infancy
+ neonatal
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: H35.1
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

👁️
Olhos
11 sintomas
❤️
Coração
1 sintomas

+ 3 sintomas em outras categorias

Características mais comuns

90%prev.
Retinopatia da prematuridade
Muito frequente (99-80%)
90%prev.
Nascimento prematuro
Muito frequente (99-80%)
90%prev.
Morfologia vascular retiniana anormal
Muito frequente (99-80%)
90%prev.
Pequeno para a idade gestacional
Muito frequente (99-80%)
17%prev.
Estrabismo
Ocasional (29-5%)
17%prev.
Descolamento tracional da retina
Ocasional (29-5%)
15sintomas
Muito frequente (4)
Ocasional (11)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 15 características clínicas mais associadas, ordenadas por frequência.

Retinopatia da prematuridadeRetinopathy of prematurity
Muito frequente (99-80%)90%
Nascimento prematuroPremature birth
Muito frequente (99-80%)90%
Morfologia vascular retiniana anormalAbnormal retinal vascular morphology
Muito frequente (99-80%)90%
Pequeno para a idade gestacionalSmall for gestational age
Muito frequente (99-80%)90%
EstrabismoStrabismus
Ocasional (29-5%)17%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico9.525PubMed
Últimos 10 anos200publicações
Pico2026140 papers
Linha do tempo
2026Hoje · 2026🧪 1986Primeiro ensaio clínico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

3 genes identificados com associação a esta condição. Padrão de herança: Not applicable.

NDPNorrinMajor susceptibility factor inRestrito
FUNÇÃO

Activates the canonical Wnt signaling pathway through FZD4 and LRP5 coreceptor. Plays a central role in retinal vascularization by acting as a ligand for FZD4 that signals via stabilizing beta-catenin (CTNNB1) and activating LEF/TCF-mediated transcriptional programs. Acts in concert with TSPAN12 to activate FZD4 independently of the Wnt-dependent activation of FZD4, suggesting the existence of a Wnt-independent signaling that also promote accumulation the beta-catenin (CTNNB1). May be involved i

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (1)
Interconversion of nucleotide di- and triphosphates
MECANISMO DE DOENÇA

Norrie disease

Recessive disorder characterized by very early childhood blindness due to degenerative and proliferative changes of the neuroretina. Approximately 50% of patients show some form of progressive mental disorder, often with psychotic features, and about one-third of patients develop sensorineural deafness in the second decade. In addition, some patients have more complex phenotypes, including growth failure and seizure.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
40.0 TPM
Ovário
39.0 TPM
Cerebelo
34.9 TPM
Brain Caudate basal ganglia
30.1 TPM
Brain Frontal Cortex BA9
27.6 TPM
OUTRAS DOENÇAS (6)
Norrie diseaseexudative vitreoretinopathy 2, X-linkedpersistent hyperplastic primary vitreousCoats disease
HGNC:7678UniProt:Q00604
LRP5Low-density lipoprotein receptor-related protein 5Major susceptibility factor inRestrito
FUNÇÃO

Acts as a coreceptor with members of the frizzled family of seven-transmembrane spanning receptors to transduce signal by Wnt proteins (PubMed:11336703, PubMed:11448771, PubMed:11719191, PubMed:15778503, PubMed:15908424, PubMed:16252235). Activates the canonical Wnt signaling pathway that controls cell fate determination and self-renewal during embryonic development and adult tissue regeneration (PubMed:11336703, PubMed:11719191). In particular, may play an important role in the development of t

LOCALIZAÇÃO

MembraneEndoplasmic reticulum

VIAS BIOLÓGICAS (1)
Negative regulation of TCF-dependent signaling by WNT ligand antagonists
MECANISMO DE DOENÇA

Vitreoretinopathy, exudative 1

An autosomal dominant disorder of the retinal vasculature characterized by an abrupt cessation of growth of peripheral capillaries, leading to an avascular peripheral retina. This may lead to compensatory retinal neovascularization, which is thought to be induced by hypoxia from the initial avascular insult. New vessels are prone to leakage and rupture causing exudates and bleeding, followed by scarring, retinal detachment and blindness. Clinical features can be highly variable, even within the same family. Patients with mild forms of the disease are asymptomatic, and their only disease related abnormality is an arc of avascular retina in the extreme temporal periphery. In many ways the disease resembles retinopathy of prematurity but there is no evidence of prematurity or small birth weight in the patient history.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
83.2 TPM
Artéria tibial
67.8 TPM
Glândula salivar
64.2 TPM
Útero
56.7 TPM
Tireoide
51.4 TPM
OUTRAS DOENÇAS (12)
polycystic liver disease 4 with or without kidney cystsobsolete bone mineral density quantitative trait locus 1autosomal dominant osteosclerosis, Worth typeosteoporosis-pseudoglioma syndrome
HGNC:6697UniProt:O75197
FZD4Frizzled-4Major susceptibility factor inModerado
FUNÇÃO

Receptor for Wnt proteins (PubMed:30135577). Most frizzled receptors are coupled to the beta-catenin (CTNNB1) canonical signaling pathway, which leads to the activation of disheveled proteins, inhibition of GSK-3 kinase, nuclear accumulation of beta-catenin (CTNNB1) and activation of Wnt target genes (PubMed:30135577). Plays a critical role in retinal vascularization by acting as a receptor for Wnt proteins and norrin (NDP) (By similarity). In retina, it can be activated by Wnt protein-binding a

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (8)
Ca2+ pathwayAsymmetric localization of PCP proteinsWNT5A-dependent internalization of FZD4Clathrin-mediated endocytosisCargo recognition for clathrin-mediated endocytosis
MECANISMO DE DOENÇA

Vitreoretinopathy, exudative 1

An autosomal dominant disorder of the retinal vasculature characterized by an abrupt cessation of growth of peripheral capillaries, leading to an avascular peripheral retina. This may lead to compensatory retinal neovascularization, which is thought to be induced by hypoxia from the initial avascular insult. New vessels are prone to leakage and rupture causing exudates and bleeding, followed by scarring, retinal detachment and blindness. Clinical features can be highly variable, even within the same family. Patients with mild forms of the disease are asymptomatic, and their only disease related abnormality is an arc of avascular retina in the extreme temporal periphery. In many ways the disease resembles retinopathy of prematurity but there is no evidence of prematurity or small birth weight in the patient history.

EXPRESSÃO TECIDUAL(Ubíquo)
Tecido adiposo
153.3 TPM
Adipose Visceral Omentum
118.7 TPM
Mama
83.3 TPM
Pulmão
72.9 TPM
Artéria coronária
62.9 TPM
OUTRAS DOENÇAS (4)
exudative vitreoretinopathy 1persistent hyperplastic primary vitreousexudative vitreoretinopathyretinopathy of prematurity
HGNC:4042UniProt:Q9ULV1

Medicamentos aprovados (FDA)

1 medicamento encontrado nos registros da FDA americana.

💊 EYLEA (AFLIBERCEPT)
Ver no DailyMed/FDA

Variantes genéticas (ClinVar)

792 variantes patogênicas registradas no ClinVar.

🧬 FZD4: NM_012193.4(FZD4):c.568C>T (p.Gln190Ter) ()
🧬 FZD4: NM_012193.4(FZD4):c.1328del (p.Leu443fs) ()
🧬 FZD4: NM_012193.4(FZD4):c.1007del (p.Gly336fs) ()
🧬 FZD4: NM_012193.4(FZD4):c.14del (p.Gly5fs) ()
🧬 FZD4: NM_012193.4(FZD4):c.470T>A (p.Met157Lys) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 1 variantes classificadas pelo ClinVar.

1
Patogênica (100.0%)
VARIANTES MAIS SIGNIFICATIVAS
FZD4: NM_012193.4(FZD4):c.766A>G (p.Ile256Val) [Conflicting classifications of pathogenicity]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
Aprovado1
3Fase 32
2Fase 23
1Fase 11
·Pré-clínico13
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Retinopatia da prematuridade

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

16 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

183 ensaios clínicos encontrados, 25 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
5.305 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 5.305

#1

Impact of a Structured Brain Care Bundle on Severe Germinal Matrix Hemorrhage-Intraventricular Hemorrhage in Very Preterm Neonates: A Retrospective Cohort Study.

Pediatric neurology2026 Feb 23

Germinal matrix hemorrhage-intraventricular hemorrhage (GMH-IVH) remains a leading cause of neurologic morbidity and mortality in very preterm infants. Evidence supports the assertion that standardized neuroprotective "Brain Care Bundles" (BCBs) can reduce GMH-IVH risk, but data from Middle Eastern Level III neonatal intensive care units are limited. We performed a retrospective cohort study comparing pre-BCBs (January-December 2021; n = 80) versus post-BCB (January-December 2022; n = 77) cohorts of inborn infants ≤30 weeks' gestation and or birth weight ≤1500 g. The ten-component BCBs included antenatal steroids, magnesium sulfate, delayed cord clamping, thermoregulation, midline head positioning, minimal handling, permissive hypercapnia, targeted oxygen saturation, hemodynamic thresholds, and neurodevelopmental support. The primary outcome was rate of severe GMH-IVH (Papile grade III-periventricular hemorrhagic infarction) on cranial ultrasound after 72 hours. Secondary outcomes included any-grade GMH-IVH, post-hemorrhagic hydrocephalus, necrotizing enterocolitis (≥stage 2), late-onset sepsis, bronchopulmonary dysplasia, retinopathy of prematurity (≥stage 3), and mortality. Baseline demographics were comparable except for a higher male proportion in the pre-BCBs cohort (63.7% vs 44.0%; P = 0.017). Delayed cord clamping and completion of antenatal steroids improved significantly post-BCBs (P < 0.05). Severe GMH-IVH incidence declined from 15% to 5% (AR = 10.2%; P = 0.045); BCBs implementation remained independently protective in multivariable analysis (adjusted odds ratio = 0.52; 95% confidence interval: 0.27-0.99; P = 0.048). Late-onset sepsis decreased markedly (P = 0.002). No significant differences were found in rates of necrotizing enterocolitis, bronchopulmonary dysplasia, retinopathy of prematurity, hydrocephalus, or mortality. Implementation of the BCBs in a high-risk Middle Eastern neonatal intensive care unit was associated with significantly reduced severe GMH-IVH and late-onset sepsis, along with better antenatal steroid adherence. These results support adopting neuroprotective BCBs as a quality improvement strategy in vulnerable preterm populations.

#2

Urinary biomarkers and serum VEGF in preterm infants with retinopathy of prematurity treated with ranibizumab.

Pediatrics international : official journal of the Japan Pediatric Society2026

Intravitreal injection of anti-vascular endothelial growth factor (VEGF) antibodies is widely used to treat retinopathy of prematurity (ROP), yet, its systemic effects remain unclear. In adults, intravitreal anti-VEGF therapy has been associated with proteinuria and acute kidney injury. This study aimed to evaluate the renal effects of anti-VEGF antibody (Ranibizumab) by longitudinally measuring urinary biomarkers and serum VEGF levels in preterm infants with ROP. Preterm infants were categorized into two groups based on ROP treatment status: those receiving intravitreal ranibizumab (IVR) (treated group) and age-matched controls without treatment (nontreated group). Urinary biomarkers, including angiotensinogen, liver-type fatty acid-binding protein (L-FABP), albumin, and podocalyxin, were assessed at three time points: before treatment, and at one and 2 months post-IVR. Serum VEGF levels were measured 1 month post-IVR. The study included 30 infants in the treated group and 12 in the nontreated group. The mean gestational age and birth weight were 24.9 weeks and 664 g in the treated group, and 26.8 weeks and 845.6 g in the nontreated group. The mean postnatal age at treatment was 68.8 days, with a postmenstrual age of 34.8 weeks. No significant differences were observed in urinary biomarker levels between the groups at one and 2 months posttreatment. Serum VEGF levels were higher in the treated group than in the nontreated group after IVR. IVR treatment did not show the sustained renal injury or suppress serum VEGF levels in preterm infants with ROP.

#3

Risk factor ranking of retinopathy of prematurity using classification and regression tree analysis.

Optometry and vision science : official publication of the American Academy of Optometry2026 Jan

Numerous risk factors for ROP have been identified, with gestational age and birth weight being the most established. Ongoing improvements in neonatal care may change the critical thresholds for these factors associated with ROP development. We applied a classification and regression tree (CART) analysis to predict the likelihood of developing ROP using a contemporary database. This cross-sectional study included 1296 premature infants who completed ROP screening by pediatric ophthalmologists from a children's hospital. Relevant infant and maternal parameters were obtained from medical records. CART analysis with the recursive partitioning package was used to predict ROP incidence, treatment need, and plus disease. The dataset was randomized, with 80% for training and 20% reserved for testing the model's accuracy. A 10-fold cross-validation was conducted to assess the model's generalizability. The mean gestational age was 27.7 ± 2.5 weeks, and the birth weight was 1017 ± 346.9 g; 538 infants developed ROP. The CART analysis produced a predictive model for ROP incidence with a mean absolute error of 0.25. The critical thresholds identified for ROP development were gestational age <27.2 weeks and birth weight <775 g. Two models for ROP progression showed that age <25 weeks and weight <569 g were linked to the need for ROP treatment, and age <24 weeks and non-Black maternal race were associated with plus disease. Our CART analysis provides updated clinical thresholds for ROP development and progression in a modern U.S. preterm population. Prospective validation across diverse populations will further enhance the model's utility and generalizability.

#4

Quantitative Assessment of the Extent of Retinal Vascularization in Retinopathy of Prematurity.

Ophthalmology science2026 Apr

To evaluate pixel-based measurements of the minimum nasal and temporal extent of retinal vascularization (NERV and TERV) from RetCam images in retinopathy of prematurity (ROP). Retrospective, multicenter diagnostic accuracy study. Infants screened for ROP at 8 high-volume centers in Imaging and Informatics in ROP (i-ROP) consortium between July 2011 and December 2016. Widefield RetCam3 temporal and nasal fundus images showing the optic disc and vascular-avascular junction were selected. A reference standard diagnosis for zone, stage, and plus disease was assigned based on indirect ophthalmoscopy and expert panel review. Each eye was also assigned an artificial intelligence-derived vascular severity score (VSS) (scale 1-9). Manual stage segmentation was performed for each image, combined with automated optic disc localization, and the Euclidean distance from the disc center to the stage was calculated in pixels to derive the NERV and TERV. Intergrader reproducibility was assessed using intraclass correlation coefficient. Minimum NERV and TERV (pixels), comparison of NERV and TERV between zone I and zone II, nasal-temporal asymmetry, area under the receiver operating characteristic curve for zone I diagnosis, and relationship between VSS, stage, and NERV/TERV. A total of 1832 images from 605 eyes of 350 infants met the inclusion criteria. Minimum NERV was shorter than minimum TERV in 98.3% of eyes, being a mean of 20.9% ± 7.9% lower. Both minimum NERV and TERV were significantly lower in zone I (276.5 ± 43.2; 345.0 ± 53.4 pixels) than zone II (360.8 ± 44.5; 452.6 ± 52.5 pixels; P < 0.0001). Area under the receiver operating characteristic curve for zone I was 0.91/0.90 for minimum NERV/TERV, respectively. The VSS was higher in eyes with a higher stage for a given extent of retinal vascularization (ERV) and higher within a given stage for eyes with a lower ERV. The intergrader reproducibility of ERV was excellent (intraclass correlation coefficient = 0.985, 95% confidence interval: 0.977 to 0.992). Objective measurement of the ERV in eyes with ROP demonstrates that the NERV is nearly always less than the TERV. These findings have implications for ROP diagnosis and classification. Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

#5

Understanding the Molecular Basis of Pathological Retinal Angiogenesis: Roles of Lipids, Non-Coding RNAs, and Cellular Crosstalk.

Investigative ophthalmology &amp; visual science2026 Mar 02

Pathological retinal neovascularization is a prevalent cause of blindness, impacting millions of individuals across all age groups, from infants to older adults. It is a key clinical feature of several retinal diseases, such as diabetic retinopathy (DR), retinopathy of prematurity (ROP), age-related macular degeneration (AMD), and Coats disease. Researchers have extensively investigated the involvement of vascular endothelial growth factor (VEGF) signaling, hypoxia inducible factor (HIF) signaling, and inflammation in the regulation of pathological retinal neovascularization. Recent breakthroughs have demonstrated the influence of several substances and cells in the retina on the regulation of pathological retinal neovascularization. This review emphasizes the rising significance of substances such as lipid mediators, non-coding ribonucleic acids, as well as the involvement of several retinal cell types, including endothelial cells (ECs), pericytes, glial cells, and the retinal pigment epithelium (RPE) in the regulation of pathological neovascularization. Here, we emphasize the interactions among these cell types in maintaining retinal homeostasis and their role in abnormal neovascularization in diseases like DR, AMD, ROP, etc. This review aims to highlight the importance of molecules and cells that go beyond the VEGF-centric therapeutic focus to treat pathological neovascularization.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC5.584 artigos no totalmostrando 197

2026

Transfusion histories of neonates who developed severe retinopathy of prematurity.

Neonatology
2025

Ferroptosis related genes in retinopathy of prematurity: Screening for potential pharmacological targets.

Molecular vision
2026

Combined use of erythropoiesis-stimulating agents and transfusion guidelines in NICU infants.

Seminars in fetal &amp; neonatal medicine
2026

Intravitreal Anti-vascular Endothelial Growth Factor in Retinopathy of Prematurity: A Bibliometric Analysis.

Journal of pediatric ophthalmology and strabismus
2026

Association Between Neighborhood Opportunity Levels and Requiring Retinopathy of Prematurity Treatment.

Journal of pediatric ophthalmology and strabismus
2026

Trends in Survival and Short-Term Outcomes Among Preterm Infants Less Than 32 Weeks From 2016 to 2022: A Retrospective Cohort Study at a Tertiary Medical Center in the UAE.

Cureus
2026

Impact of Omega-3 Enriched Lipid Emulsions on Retinopathy of Prematurity in Very Low Birth Weight Infants: A Retrospective Cohort Analysis - Authors' Reply.

Indian journal of pediatrics
2026

Impact of a Structured Brain Care Bundle on Severe Germinal Matrix Hemorrhage-Intraventricular Hemorrhage in Very Preterm Neonates: A Retrospective Cohort Study.

Pediatric neurology
2026

360-Degree Sclerosed Vessels and Candle Wax-Like Deposits as an Atypical Exudative Presentation of Aggressive Retinopathy of Prematurity in a Neonate With Severe Anaemia.

Cureus
2026

Urinary biomarkers and serum VEGF in preterm infants with retinopathy of prematurity treated with ranibizumab.

Pediatrics international : official journal of the Japan Pediatric Society
2026

Impact of Omega-3 Enriched Lipid Emulsions on Retinopathy of Prematurity in Very Low Birth Weight Infants: A Retrospective Cohort Analysis - Correspondence.

Indian journal of pediatrics
2026

Risk factor ranking of retinopathy of prematurity using classification and regression tree analysis.

Optometry and vision science : official publication of the American Academy of Optometry
2026

Quantitative Assessment of the Extent of Retinal Vascularization in Retinopathy of Prematurity.

Ophthalmology science
2026

Long-Term Peripheral Vitreoretinal Interface Abnormalities of Retinopathy of Prematurity: Ultra-Wide Field Optical Coherence Tomography Findings.

Clinical &amp; experimental ophthalmology
2026

WAVY OBLONG RETROGRADE MOVING SEGMENTS (WORMS) INTRAVENOUS FLUORESCEIN ANGIOGRAPHIC FINDING IN A NEONATE WITH RETINOPATHY OF PREMATURITY.

Retinal cases &amp; brief reports
2026

From Science and Technology to Eye-Health Policy: A Review on Global and Asia-Pacific Strategies on the Prevention of Blindness from Retinal Diseases.

Ophthalmology and therapy
2026

Understanding the Molecular Basis of Pathological Retinal Angiogenesis: Roles of Lipids, Non-Coding RNAs, and Cellular Crosstalk.

Investigative ophthalmology &amp; visual science
2026

Trends in retinopathy of prematurity (ROP) training and future practice intentions among retina and pediatric ophthalmology fellows.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2026

Polyunsaturated Fatty Acid Balance Modulates Microglial State in a Murine Model of Oxygen-Induced Neovascularization.

Nutrients
2026

Use of Aflibercept to Treat Retinopathy of Prematurity in Children with Extremely Low Birth Weight.

Journal of clinical medicine
2026

Association between risk-adjusted mortality and severe morbidity in very low birth weight infants: a multicenter study from the NEOCOSUR network.

Journal of perinatology : official journal of the California Perinatal Association
2026

The impact of Assisted Reproductive Technology on the neonatal prognosis of newborns < 29 weeks gestational age: a retrospective case-control study.

Journal of gynecology obstetrics and human reproduction
2026

Delays and loss to follow-up in outpatient retinopathy of prematurity screening.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2026

Association of red blood cell transfusions with periventricular leukomalacia in very preterm infants.

Vox sanguinis
2026

Ophthalmic manifestations in preterm children without retinopathy of prematurity: A review.

Survey of ophthalmology
2026

Characterizing the Treatment Courses of Ranibizumab and Panretinal Photocoagulation for Retinopathy of Prematurity.

Journal of pediatric ophthalmology and strabismus
2026

Efavirenz treatment improves retinal vaso-obliteration and pathological neovascularization in a mouse model of retinopathy of prematurity.

Frontiers in medicine
2026

Risk factors and prevalence of retinopathy of prematurity in very low birth weight preterm infants: a systematic review and meta-analysis.

Translational pediatrics
2026

A Multidisciplinary Approach in the Management of Aggressive Retinopathy of Prematurity With Bleb-Like Posterior Combined Retinal Detachment.

Cureus
2026

Neurodevelopmental Outcomes of Isolated Cerebellar Pathologies in Extremely Preterm Infants.

Pediatrics
2026

Management of Retinopathy of Prematurity in the United Arab Emirates: A Consensus Statement From the Emirates Society of Ophthalmology.

Cureus
2026

High-Frequency Oscillation vs Mechanical Ventilation for Neonatal Acute Respiratory Distress Syndrome: A Randomized Clinical Trial.

JAMA network open
2026

Prevalence, perinatal risk factors and clinical outcomes of respiratory Ureaplasma species colonization in hospitalized preterm infants.

Frontiers in pediatrics
2026

Efficacy and factors associated with reactivation following intravitreal ranibizumab or conbercept for retinopathy of prematurity.

Frontiers in medicine
2026

Efficacy and safety of conbercept, ranibizumab and laser in retinopathy of prematurity: a systematic review and network meta-analysis.

Survey of ophthalmology
2026

Clinical exposure thresholds associated with retinopathy of prematurity in preterm infants born at high altitude.

Respiratory physiology &amp; neurobiology
2026

Degree of thrombocytopenia and severity of retinopathy of prematurity.

Journal of perinatology : official journal of the California Perinatal Association
2026

Multi-enzyme nanozyme targeting redox-senescence-angiogenesis axis ameliorates pathological angiogenesis in retinopathy models.

Biomaterials science
2026

Exploiting porphyrin metabolism to inhibit angiogenesis.

Angiogenesis
2026

Evaluation of the prognostic nutritional index in preterm infants: A retrospective study examining its relationship with retinopathy of prematurity and clinical risk factors.

Journal of neonatal-perinatal medicine
2026

Clinical predictors of disease severity in nasal versus temporal retinopathy of prematurity.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
2026

Mathematical Modeling of Human Retinal Vascular Pattern Around the Foveal Avascular Zone.

Translational vision science &amp; technology
2026

Adherence to Pediatric Ophthalmology Follow-Up After Completion of Retinopathy of Prematurity: A Retrospective Review.

Patient preference and adherence
2026

Direct infusion nano-electrospray ionization mass spectrometry for untargeted metabolomics of trace-volume aqueous humor from prematurity infants.

Talanta
2026

OCT findings as a biomarker of disease activity in retinopathy of prematurity.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2026

P-Score Variability as a Function of Retinopathy of Prematurity Severity.

Investigative ophthalmology &amp; visual science
2026

Pulse Oximetry Histogram Profiles Before and After Red Blood Cell Transfusion in Very Preterm Infants: A Prospective Observational Cohort.

Children (Basel, Switzerland)
2026

The Clinical Association of Maternal Asthma and the Development of Retinopathy of Prematurity in Preterm Infants.

Journal of vitreoretinal diseases
2026

In-Hospital Outcomes of Very Preterm and Very Low Birth Weight Neonates: A Multicenter Retrospective Study from India.

Indian pediatrics
2026

Multi-site performance of the telemedicine retinopathy of prematurity severity score (tROP-SS).

Acta ophthalmologica
2026

Misdiagnosis in Referrals for Advanced Retinopathy of Prematurity.

Ophthalmology. Retina
2026

Angiogenic factors and fetal Doppler for predicting adverse pregnancy outcome in early-onset small fetuses with and without pre-eclampsia.

Ultrasound in obstetrics &amp; gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
2026

Safety and Efficiency Reducing Retinopathy of Prematurity Guideline Sensitivity: An External Validation Using a Large US-based Dataset.

American journal of ophthalmology
2026

Early vitrectomy for macular retinoschisis after anti-VEGF therapy in aggressive retinopathy of prematurity.

American journal of ophthalmology
2026

Anti-Vascular Endothelial Growth Factor Drugs Restore Glial-Vascular Interaction in a Rat Model of Retinopathy of Prematurity.

Current eye research
2026

Outcomes and complications of invasive versus non-invasive respiratory support in extremely preterm infants: a retrospective study.

BMC pediatrics
2026

Variations in prevalence of retinopathy of prematurity (ROP) and completeness of screening in five units within a South African region: a register-based study.

Eye (London, England)
2026

Assessing the Prevalence and Determinants of Retinopathy of Prematurity in King Saud Medical City, Saudi Arabia.

Cureus
2025

Parental Awareness of Retinopathy of Prematurity in Türkiye: A Cross-Sectional Study.

Sisli Etfal Hastanesi tip bulteni
2026

Can provision of near vision glasses as an early intervention improve visual outcomes in infants at risk of perinatal brain insult? The Babies in Glasses (BiG) randomised feasibility trial.

BMJ open
2025

Beyond anti-VEGF: expanding the therapeutic horizon and biomarker landscape in retinopathy of prematurity.

Frontiers in pediatrics
2026

Parenteral nutrition use and recurrence requiring retreatment of retinopathy of prematurity after anti-VEGF monotherapy: a retrospective cohort study of preterm infants.

BMC pediatrics
2026

Automatic versus manual control of oxygen and neonatal clinical outcomes in extremely preterm infants: a multicentre, parallel-group, randomised, controlled, superiority trial.

The Lancet. Child &amp; adolescent health
2026

Comparison of ChatGPT-4 and ChatGPT-4 Plus Responses to Retinopathy of Prematurity-Related Questions and Performance Evaluation in Different Languages.

Journal of pediatric ophthalmology and strabismus
2026

Stress exposure, stress responses, and short-term outcomes in very preterm neonates: a national cohort study.

European journal of pediatrics
2026

[Treatment of retinopathy of prematurity (ROP) : S1 guidelines of the German Society of Ophthalmology (DOG), the German Retina Society (RG), the German Professional Association of Ophthalmologists (BVA), the Federal Association "The Premature Infant", the German Federation of the Blind and Partially Sighted (DBSV), PRO RETINA Germany].

Die Ophthalmologie
2026

Analytical study of influence of polymorphisms of VEGF+936T/C, ACE ID, TNF308G/A, and GSTP1 genes on retinopathy of prematurity progression/regression.

Indian journal of ophthalmology
2025

Elective HFOV vs CMV as Early Intervention: A Clinical Trial in Neonates with Acute Respiratory Distress Syndrome.

Advanced biomedical research
2026

Azithromycin therapy for prevention of chronic lung disease of prematurity (AZTEC): a randomised placebo-controlled trial.

Health technology assessment (Winchester, England)
2026

Impact of multiple births on retinopathy of prematurity in preterm infants.

Eye (London, England)
2026

Apgar Score Plus Umbilical Artery pH and Adverse Neonatal Outcomes in Very Preterm Infants.

JAMA network open
2026

Phosphatidylserine exposure by developing astrocytes initiates microglia-mediated developmental cell death.

bioRxiv : the preprint server for biology
2026

From Pathway to Practice: Implementing Evidence-Based Quality Improvement for ELBW Care.

American journal of perinatology
2026

Automated diagnosis of plus form and early stages of ROP using deep learning models.

Scientific reports
2026

The relationship between maternal cannabis use disorder diagnosis and the development of retinopathy of prematurity.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2026

Pannexin-1 Inhibits Pathologic Neovascularization in Oxygen-Induced Retinopathy by Targeting the HIF-1α/VEGF Pathway in Vitro.

Current eye research
2025

Reflections of the 2021 update of the retinopathy of prematurity (ROP) guideline: a single-center retrospective comparative cohort analysis.

The Turkish journal of pediatrics
2025

Predictive value of serum hsa_circ_0061346, hsa_circ_0000095, and hsa_circ_0068606 expression levels on the severity of retinopathy of prematurity.

The Turkish journal of pediatrics
2026

Infographic: bevacizumab eliminates the angiogenic threat of retinopathy of prematurity (BEAT-ROP study).

Eye (London, England)
2026

Computational Vascular Development Model Explaining Incidence of Notch in Retinopathy of Prematurity With Ultra-Widefield Optical Coherence Tomography.

Investigative ophthalmology &amp; visual science
2026

Clinical, demographic, and socioeconomic factors associated with outpatient retinopathy of prematurity follow-up.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2026

Automated Feature Segmentation of Ultra-Widefield OCT Images.

Ophthalmology science
2025

Evidence summary for pain management during retinopathy of prematurity screening.

Frontiers in pediatrics
2026

Global Validation of the Postnatal Growth and Retinopathy of Prematurity Screening Model: A Systematic Review and Meta-Analysis.

Ophthalmology. Retina
2026

Preappointment dilation drops for retinopathy of prematurity examination visits: an equitable intervention to reduce clinic time regardless of insurance status.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2026

Fundus image quality assessment in retinopathy of prematurity via multi-label graph evidential network.

Medical image analysis
2026

Anti-VEGF versus laser therapy for retinopathy of prematurity: a systematic review and meta-analysis focusing on recurrence patterns and retreatment needs.

International journal of retina and vitreous
2026

Perinatal and Maternal Outcomes by Indication for Delivery in the Second Trimester.

American journal of perinatology
2026

Risk factors and analysis of retinopathy of prematurity in monochorionic diamniotic twins.

Journal of perinatal medicine
2026

Fatty Acid Supplementation and Retinopathy of Prematurity: Secondary Analysis of a Randomized Clinical Trial.

JAMA ophthalmology
2026

Macular development in preterm twins with and without retinopathy of prematurity: an OCT angiography study from the Shenzhen prematurity eye study.

European journal of medical research
2026

LncRNA KCNQ1OT1 modulates M2 macrophage polarization and angiogenic signaling via the miR-142-3p/TRIM24 axis in retinal neovascularization.

Archives of biochemistry and biophysics
2026

Global, regional and national patterns in ROP research up to the pre-COVID-19 era: A systematic bibliometric review between 1950 to 2020.

European journal of ophthalmology
2026

Myopia of Prematurity: Reduced Progression Using Highly Aspherical Lenslet Target (HALT) Technology.

Journal of clinical medicine
2026

Early Nutritional Patterns and Metabolic Biomarkers Associated with ROP Severity.

Medicina (Kaunas, Lithuania)
2026

Identifying the risk factors of autism spectrum disorders in infants born preterm: a systematic review and meta-analysis.

European child &amp; adolescent psychiatry
2026

The Effect of Vitamin A and Retinol-Binding Protein Levels in Cord Blood of Very Low Birth Weight Infants on Mortality and Morbidity.

Klinische Padiatrie
2026

The understated role of mothers in decision-making for retinopathy of prematurity management in India.

Indian journal of ophthalmology
2026

Deep Learning-Based Prediction of Cardiopulmonary Disease in Retinal Images of Premature Infants.

JAMA ophthalmology
2025

Study protocol for the volume targeted mask ventilation versus pressure ventilation in preterm infants-the VOLT-trial.

Frontiers in pediatrics
2026

Quantitative assessment of neonatal health using dried blood spot metabolite profiles and deep learning.

Science translational medicine
2026

Optimised multivariable prediction model to predict treatment requirement in preterm infants with retinopathy of prematurity.

Eye (London, England)
2026

Prediction of Retinopathy of Prematurity and Treatment in Very Low Birth Weight Infants Using Machine Learning on Nationwide Non-Imaging Clinical Data.

Neonatology
2026

Epigenetic age and neurodevelopmental outcomes in children born preterm.

Genetics in medicine open
2026

Fetal hemoglobin fraction is correlated to the risk of prematurity complications.

The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
2026

NLP-ROPCare: predicting retinopathy of prematurity with admission notes using natural language processing.

BMJ open ophthalmology
2026

Severe Posterior Retinopathy of Prematurity: A Matched Cohort Analysis.

Ophthalmology. Retina
2026

Non-neuronal cell microenvironment control retinal vascular remodeling by CST3 in the oxygen-induced retinopathy in mice.

Experimental eye research
2026

Ten-year changes in risk factors for requiring treatment of retinopathy of prematurity in extremely low birth weight infants: a multicenter study in Tokyo.

Japanese journal of ophthalmology
2026

Infographic: Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW and RAINBOW Extension Study).

Eye (London, England)
2026

An Interventional Study on the Late Treatment of Severe Bronchopulmonary Dysplasia in Preterm Infants Using Mesenchymal Stromal Cells.

Stem cells international
2026

Validating DevCheck: a semi-automated computer algorithm for measuring foveal immaturity in premature infants.

Quantitative imaging in medicine and surgery
2026

Bilateral vitrectomy in retinopathy of prematurity: reported outcomes across studies.

Eye (London, England)
2026

Antibiotic exposure in culture-negative preterm infants: a 10-year single-centre study.

Pediatric research
2026

Evaluation of the frequency, risk factors and outcomes of ROP in preterm infants with a BW >1500 g or GA >32 weeks in Turkiye (TR-ROP 2) and medicolegal fears: a Turkish Neonatal Society multicentre study.

The British journal of ophthalmology
2026

Hypertensive disorders of pregnancy and retinopathy of prematurity in extremely preterm infants: A causal mediation analysis.

Pregnancy hypertension
2026

Three-Year Outcomes of Intravitreal Aflibercept versus Laser Therapy for Retinopathy of Prematurity: Interim Analysis of the Efficacy and Safety Outcomes in the FIREFLEYE next Trial.

Neonatology
2026

Proteomic Profile in Retinopathy of Prematurity: A Secondary Analysis of the Mega Donna Mega Randomized Clinical Trial.

JAMA ophthalmology
2025

Protective Effects of Butyrate on Retinal Neovascularization in Preclinical Retinopathy of Prematurity Models.

bioRxiv : the preprint server for biology
2026

Aggressive-Retinopathy of Prematurity or Oxygen-Induced Retinopathy?

Ophthalmology. Retina
2026

Cerebral near-infrared spectroscopy monitoring for prevention of death or neurodevelopmental disability in very preterm infants.

The Cochrane database of systematic reviews
2026

Retinopathy of prematurity screening program for government neonatal intensive care units by a non-profit tertiary eye care center in India: A collaborative public health initiative.

Indian journal of ophthalmology
2026

Scleral buckling in stage 4A/B retinopathy of prematurity: A retrospective analysis of 105 eyes.

Indian journal of ophthalmology
2026

General movements and neurodevelopmental outcomes at 2 years of age in infants born very preterm.

Developmental medicine and child neurology
2026

A direct method for imaging gradient levels of retinal hypoxia in a model of retinopathy of prematurity (ROP).

BMC ophthalmology
2026

Suboptimal visual acuity and neurodevelopment at five years in children born very preterm: the EPIPAGE-2 cohort study.

Archives of disease in childhood. Fetal and neonatal edition
2026

Effects of Kangaroo care during retinopathy screening examination: a randomised clinical trial.

BMJ paediatrics open
2026

Delayed choroidal perfusion: a fluorescein angiographic finding in retinopathy of prematurity.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
2025

The relationship of p50 with clinical outcomes in ventilated preterm infants.

Frontiers in pediatrics
2026

Ophthalmic manifestations associated with eyelid hyperlaxity in Indian subcontinent.

European journal of ophthalmology
2025

Cost Analysis of Risk-Stratified Retinopathy of Prematurity Screening.

Ophthalmology. Retina
2025

Modelling direct healthcare costs for screening and treatment of retinopathy of prematurity among infants born at gestational age <24 weeks: findings from a Swedish cohort.

BMJ open ophthalmology
2025

Associations Between Fetal Symptoms During Pregnancy and Neonatal Clinical Complications with Cytomegalovirus Infection.

Children (Basel, Switzerland)
2025

Long-Term Outcome of Xenon-Arc Photocoagulation for Retinopathy of Prematurity in the 1970s in Japan: Eleven Patients With 32- to 49-Year Follow-Up.

Cureus
2025

ROP mimicker in a big premature baby: Adams-Oliver syndrome with DOCK6 mutation: a case report and review of the literature.

Ophthalmic genetics
2026

Ocular surface inflammatory cytokines as a biomarker for retinopathy of prematurity.

Eye (London, England)
2026

Global and Regional Trends in Retinopathy of Prematurity.

JAMA ophthalmology
2026

The Global Epidemiologic Transition of Retinopathy of Prematurity: Interpreting Forecasts Through a Health-System Lens.

JAMA ophthalmology
2026

LncRNA DANCR Activates p38/mTOR-Mediated Autophagy via ANXA2 to Exacerbate Oxygen-Induced Retinal Neovascularization in Mice.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2025

Macretina: a dataset, to support deep learning assisted retinopathy of prematurity diagnosis.

Scientific reports
2025

The Burden of Retinopathy of Prematurity in Albania: A Nationwide Observational Study.

Cureus
2025

Prevalence and associated factors of retinopathy of prematurity in sub‑Saharan Africa: a systematic review and meta‑analysis.

BMC ophthalmology
2025

Impact of bronchopulmonary dysplasia, brain injury, necrotizing enterocolitis, retinopathy of prematurity and sepsis on neurodevelopmental outcomes in premature infants.

Journal of perinatology : official journal of the California Perinatal Association
2026

Enhancing deep learning telemedicine for retinopathy of prematurity: current evidence and opportunities for improvement.

Eye (London, England)
2025

Development and validation of a pre-trained language model for neonatal morbidities: a retrospective, multicentre, prognostic study.

The Lancet. Digital health
2026

Prediction of Language Development in Neonates Born at Less than 32 Weeks of Gestation.

The Journal of pediatrics
2025

Screening of at-risk ROP patients: use of a single small field image centred on the optic disc.

Archives of disease in childhood. Fetal and neonatal edition
2025

Spiderweb-like Vessels in Retinopathy of Prematurity. Reply.

The New England journal of medicine
2025

Spiderweb-like Vessels in Retinopathy of Prematurity.

The New England journal of medicine
2026

Critical Commentary on 'Multisensory Stimulation to Reduce Procedural Pain in Retinopathy of Prematurity: A Randomised Controlled Trial'.

Nursing in critical care
2026

Neonatal Multimorbidity is a Poor Predictor of Health and Developmental Outcomes after Preterm Birth.

The Journal of pediatrics
2026

Association between Infant Birth Size Classification and Development of Morbidities in the Neonatal Intensive Care Unit: A Cohort Study.

Neonatology
2025

Development of a non-invasive diagnostic model for severe Retinopathy of Prematurity integrating clinical and platelet data.

Scientific reports
2025

[Risk factors and prognosis of first extubation failure in neonates undergoing invasive mechanical ventilation].

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
2025

The prevalence, risk factors and outcomes of retinopathy of prematurity at a tertiary care centre in South Africa.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
2025

Role of Angiogenesis in Retinal Diseases and New Advances in Drug Development.

Cells
2025

Role of Multimodal Imaging in the Diagnosis and Management of Endogenous Candida Endophthalmitis in a neonate with Aggressive Retinopathy of Prematurity.

Retinal cases &amp; brief reports
2026

Glial fibrillary acidic protein, an early and sustained indicator of retinopathy progression.

Experimental eye research
2025

Outcomes and antimicrobial usage in preterm neonates < 34 weeks gestation with culture-negative neonatal sepsis: a prospective observational study.

BMC infectious diseases
2025

Conformational Dynamics of PKM2 Regulate Hypoxia-Induced Pathological Retinal Angiogenesis.

Investigative ophthalmology &amp; visual science
2026

Fish Oil-Containing Lipid Emulsion and Retinopathy of Prematurity: Signal, Selection, or Secular Trend.

Indian journal of pediatrics
2026

The Safety and Efficacy of Anti-Vascular Endothelial Growth Factor Biosimilars in Retinopathy of Prematurity.

Acta paediatrica (Oslo, Norway : 1992)
2025

Validation of the 'TWO-ROP' algorithm in a tertiary Care Centre in Greece.

Acta ophthalmologica
2025

Dual-Stream Cross-Fusion Learning For Retinopathy of Prematurity Fundus Image Quality Assessment.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
2025

CNN-Mamba Interaction Fusion Network for Diagnosis Retinopathy of Prematurity.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
2025

Investigating Predictors of Retreatment following Initial Antivascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis.

Journal of current ophthalmology
2025

Topical Fasudil in Type 2 Retinopathy of Prematurity: A Pilot Study.

Journal of current ophthalmology
2025

Obstructive uropathy in a female infant with a single kidney: Unmasking congenital urethral stenosis: A case report and review of the literature.

International journal of surgery case reports
2025

Hematocrit in the first 2 hours of life and short-term outcomes in very preterm infants: A secondary analysis from a prospective cohort study.

PloS one
2025

Real-World Visual and Anatomical Outcomes of Laser Therapy versus Intravitreal Anti-Vascular Endothelial Growth Factor Injection for Retinopathy of Prematurity: A 10-Year Retrospective Cohort Study at a Tertiary Center in Thailand.

Clinical ophthalmology (Auckland, N.Z.)
2025

Flow-Driver-Generated Synchronized Nasal Intermittent Positive-Pressure Ventilation Versus Biphasic Positive Airway Pressure After Extubation in Preterm Infants.

Pediatric pulmonology
2025

[Clinical analysis of 33 cases of fetomaternal hemorrhage syndrome].

Zhonghua fu chan ke za zhi
2025

In-hospital and neurodevelopmental outcomes of treatment strategies for patent ductus arteriosus in preterm infants: A retrospective cohort study.

Pediatrics and neonatology
2025

Prevalence of retinopathy of prematurity in African preterm infants and evaluation of the accuracy of the WINROP predictive algorithm: an observational clinical study.

BMC ophthalmology
2025

OCTA-based evaluation of the correlation between macular retinal and choroidal structural characteristics and refractive status in patients with retinopathy of prematurity.

Frontiers in pediatrics
2025

Visualization of the Persistent Avascular Retina with Ultra-Widefield Green Reflectance Imaging.

Diagnostics (Basel, Switzerland)
2025

Closed-Loop Automated Oxygen Control in Preterm Infants Receiving Non-Invasive Respiratory Support.

Children (Basel, Switzerland)
2025

The nucleated red blood cell count at birth, the volume of red cell transfusions received, and the risk of developing retinopathy of prematurity.

Journal of perinatology : official journal of the California Perinatal Association
2025

Perspectives on screening in retinopathy of prematurity: new algorithms and AI tools.

Clinical &amp; experimental optometry
2025

Pattern of Independent Factors Influencing Preterm Infants' Chance of Survival to Discharge Without Any Significant Morbidities.

Cureus
2025

Long-term Outcome of Anti-VEGF Treatment in Retinopathy of Prematurity: A 12-Year Follow-Up with Ultra-Widefield Imaging.

Retinal cases &amp; brief reports
2025

Dual-Scale Swin Transformer via Feature Alignment and Adversarial Discrimination for Retinopathy of Prematurity Diagnosis.

IEEE journal of biomedical and health informatics
2026

Population-Based Cohort Study for Development of National Retinopathy of Prematurity Screening Criteria.

Acta paediatrica (Oslo, Norway : 1992)
2025

Management of retinopathy of prematurity in a tertiary referral neonatal intensive care unit: Treatment rates and the impact of outsourcing laser therapy.

Acta ophthalmologica
2026

Automated diagnosis of early-stage retinopathy of prematurity.

Eye (London, England)
2025

Influence of Neonatal Exposure to Hyperoxia on Skeletal Muscle in a Rat Model.

Pediatric reports
2025

CYP46A1 Activation Improves Retinal Neovascularization in a Mouse Model of Retinopathy of Prematurity.

bioRxiv : the preprint server for biology
2025

External validation of an artificial intelligence-based model for retinopathy of prematurity screening using Phoenix ICON retinal images.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2025

Predictors of persistent avascular retina in retinopathy of prematurity treated with intravitreal ranibizumab.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2026

Optimization of the oxygen-induced retinopathy model in mice and its impact on retinal angiogenesis.

Experimental eye research
2025

Evaluating the G-ROP criteria sensitivity for type 1 ROP in a North American cohort.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2025

Does field of view matter? Assessing its impact on Plus disease diagnosis in retinopathy of prematurity.

International journal of retina and vitreous
2025

A novel method of quantifying retinal vascular tortuosity in retinopathy of prematurity.

Scientific reports
2025

Pediatric teleophthalmology screening: a scoping review of global evidence and implications for Canada.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
2026

Yield of Early Examination for Aggressive Retinopathy of Prematurity: A Retrospective Study.

Indian pediatrics
2026

EBNEO Commentary: Cord Blood Red Cell Transfusions and Severe Retinopathy of Prematurity in Preterm Neonates.

Acta paediatrica (Oslo, Norway : 1992)
2025

Late Reactivation of Retinopathy in a Treatment-Naive Female Adult Patient With History of Prematurity and ZNF408 Mutation.

Journal of vitreoretinal diseases
Ver todos os 5.584 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Retinopatia da prematuridade.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Retinopatia da prematuridade

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Impact of a Structured Brain Care Bundle on Severe Germinal Matrix Hemorrhage-Intraventricular Hemorrhage in Very Preterm Neonates: A Retrospective Cohort Study.
    Pediatric neurology· 2026· PMID 41855703mais citado
  2. Urinary biomarkers and serum VEGF in preterm infants with retinopathy of prematurity treated with ranibizumab.
    Pediatrics international : official journal of the Japan Pediatric Society· 2026· PMID 41852194mais citado
  3. Risk factor ranking of retinopathy of prematurity using classification and regression tree analysis.
    Optometry and vision science : official publication of the American Academy of Optometry· 2026· PMID 41848196mais citado
  4. Quantitative Assessment of the Extent of Retinal Vascularization in Retinopathy of Prematurity.
    Ophthalmology science· 2026· PMID 41847074mais citado
  5. Understanding the Molecular Basis of Pathological Retinal Angiogenesis: Roles of Lipids, Non-Coding RNAs, and Cellular Crosstalk.
    Investigative ophthalmology &amp; visual science· 2026· PMID 41837574mais citado
  6. Advancing vision care in children - bridging science, policy, and practice.
    BMC Pediatr· 2026· PMID 41987103recente
  7. Insulin-like growth factor-1 for the prevention or treatment of retinopathy of prematurity.
    Cochrane Database Syst Rev· 2026· PMID 41983451recente
  8. Changing Trends in Childhood Blindness in Schools for the Visually Impaired in India: A Structured Literature Review.
    J Curr Ophthalmol· 2025· PMID 41982837recente
  9. Retinal Vascularization Timeline following Intravitreal Bevacizumab Injection in Infants with Retinopathy of Prematurity: A Retrospective Study.
    J Curr Ophthalmol· 2025· PMID 41982833recente
  10. Effectiveness and safety of intranasal fentanyl for pain management in infants aged 0-6 months of age: a systematic review.
    JBI Evid Synth· 2026· PMID 41978431recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:90050(Orphanet)
  2. MONDO:0006952(MONDO)
  3. GARD:5695(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Artigo Wikipedia(Wikipedia)
  7. Q1423087(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Retinopatia da prematuridade
Compêndio · Raras BR

Retinopatia da prematuridade

ORPHA:90050 · MONDO:0006952
Prevalência
1-5 / 10 000
Herança
Not applicable
CID-10
H35.1 · Retinopatia da prematuridade
CID-11
Ensaios
25 ativos
Início
Infancy, Neonatal
Prevalência
0.0 (Europe)
MedGen
UMLS
C0035344
EuropePMC
Wikidata
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades